Kynurenine-PARP-1 Link Mediated by MicroRNA 210 May Be Dysregulated in Pulmonary Hypertension

Alperen Emre Akgün1, Yalın Tolga Yaylalı2, Mücahit Seçme3

  • 1Department of Cardiology, Uşak Training and Research Hospital, Uşak, Turkey.

Abstract

Insights

MicroRNA-130a and Apelin are key risk factors for pulmonary hypertension (PH). Their dysregulation, along with altered kynurenine and poly-ADP-ribose polymerase-1 pathways, impacts PH severity and hemodynamics.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Biochemistry

Background:

  • MicroRNA (miRNA) dysregulation is implicated in the pathogenesis of pulmonary hypertension (PH).
  • Understanding miRNA alterations and their associated signaling pathways is crucial for PH research.
  • Serum biomarkers like apelin, kynurenine, and endocan may provide insights into PH mechanisms.

Purpose of the Study:

  • To investigate alterations in specific microRNA and mRNA expressions in patients with precapillary pulmonary hypertension.
  • To explore the role of these molecular changes in relevant signaling pathways.
  • To examine the relationship between these molecular markers and serum levels of apelin, kynurenine, and endocan in PH.

Main Methods:

  • Prospective, single-center study involving 32 treatment-naive PH patients and 55 healthy controls.
  • Right heart catheterization performed on all subjects.
  • RT-PCR used to quantify mRNA (HIF-1α, HIF-2α, STAT3, FGF2, FGFR1, PARP-1) and miRNA (miRNA-210, miRNA-130a, miRNA-424, miRNA-204, miRNA-223) expressions.
  • ELISA used to measure serum concentrations of kynurenine, apelin, and endocan.

Main Results:

  • Elevated mRNA expressions of HIF-2α, STAT3, and FGF-2; increased miRNA-210 and miRNA-130a; decreased miRNA-223 and miRNA-204 observed in PH patients.
  • Reduced serum levels of apelin and kynurenine found in PH.
  • Positive correlations identified between HIF-2α/miRNA-424, Apelin/miRNA-424, kynurenine/miRNA-210, STAT3/PVR, miRNA-210/right atrial pressure, and kynurenine/right atrial pressure.
  • Negative correlations noted between PARP-1/miRNA-210 and PARP-1/right atrial pressure.
  • miRNA-130a and Apelin identified as independent risk factors for PH via logistic regression.

Conclusions:

  • A novel link between kynurenine and PARP-1 signaling, potentially mediated by miRNA-210, is reported.
  • A connection between Apelin and HIF-2α signaling, possibly mediated by miRNA-424, is suggested.
  • Reduced Apelin and elevated miRNA-130a are associated with pulmonary hypertension.
  • Increased STAT3, miRNA-210, kynurenine, and decreased PARP-1 correlate with more severe hemodynamics in PH.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
302
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.9K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
234
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
266
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K